Flowserve Corporation Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Flowserve Corporation Common Stock trades at $70.6 (market cap $8.96B), while Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 4.8× Flowserve Corporation Common Stock's market cap, and Flowserve Corporation Common Stock pays a 1.25% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FLS | RVMD | |
|---|---|---|
Market Cap | $8.96B | $43.07B |
Volume | 1,946,178 | 1,184,841 |
Sector | Industrials | Health |
52-Week High | $92.04 | $221.15 |
52-Week Low | $49.09 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.55B | $39.77B |
Dividend Yield | 1.25% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →